The variability of plasma NfL across cognitive decline stages (Mielke et al. 2019) suggests diverse clinical presentations and potential comorbidities (Ashton et al. 2021; Narayanan et al. 2021). The gene discussed is NEFL; the disease is Mental deterioration.